Soluble epoxide hydrolase inhibition avoid formalin-induced inflammatory hyperalgesia in the temporomandibular joint

• Published in: Inflammopharmacology 2022-06, Vol.30 (3), p.981-990
• Main Authors: Abdalla, Henrique Ballassini, Napimoga, Marcelo Henrique, Teixeira, Juliana Maia, Trindade-da-Silva, Carlos Antônio, Pieroni, Victor Luís, dos Santos Araújo, Fernanda Souto Maior, Hammock, Bruce D., Clemente-Napimoga, Juliana Trindade
• Format: Article
• Language: English
• Subjects: Allergology; Analgesics - therapeutic use; Animals; Anti-Inflammatory Agents - therapeutic use; Biomedical and Life Sciences; Biomedicine; Cytokines - metabolism; Dermatology; Epoxide Hydrolases - metabolism; Formaldehyde - pharmacology; Gastroenterology; Hyperalgesia - chemically induced; Hyperalgesia - drug therapy; Hyperalgesia - pathology; Immunology; Lipids; Original Article; Pharmacology/Toxicology; Phenylurea Compounds - toxicity; Piperidines - pharmacology; Rats; Rheumatology; Temporomandibular Joint - metabolism; Temporomandibular Joint - pathology
• ISSN: 0925-4692; 1568-5608
• DOI: 10.1007/s10787-022-00965-5

Epoxyeicosatrienoic acids (EETs) are endogenous molecules that exerts effective antinociceptive and resolutive actions. However, because of their rapid metabolism by the soluble epoxide hydrolase (sEH), EETs are unable to remain bioavailable. Therefore, the aim of this study was to investigate whether local sEH inhibition could prevent inflammatory hyperalgesia in the temporomandibular joint (TMJ) of rats. For that, rats were pre-treated with an intra-TMJ injection of TPPU, followed by the noxious stimulus (1.5% of formalin intra-articular) to evaluate nociceptive behavior. Histological analysis was conducted to explore the inflammatory exudate and mast cell degranulation. Periarticular tissue over the TMJ was used to measure inflammatory lipids and cytokines/chemokine by Enzyme-Linked Immunosorbent Assay (ELISA). We demonstrated that peripheral pretreatment with TPPU prevents formalin-induced inflammatory hyperalgesia in the TMJ, and this effect is strictly local. Moreover, TPPU mitigates the leukocyte exudate in the TMJ, as well as inflammatory lipids mediators. Mast cell number and degranulation were abrogated by TPPU, and the inflammatory cytokine levels were decreased by TPPU. On the other hand, TPPU up-regulated the release of interleukin 10 (IL-10), an anti-inflammatory cytokine. We provide evidence that locally sEH by intra-TMJ injection of TPPU produces an antinociceptive and anti-inflammatory effect on rats' TMJ.